4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001628280-25-054270
EVP, GC & Business Development sold 20,916 shares at $12.00 ($250,992)
- EVP, GC & Business Development acquired 8,977 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Olivo Alicia C EVP, GC & Business Development | 2025-11-25 | Option exercise 10b5-1 | +8,977 | $10.05 | $90,219 | 51,999 | D: show line 1 in the form |
| Olivo Alicia C EVP, GC & Business Development | 2025-11-25 | Sale 10b5-1 | −20,916 | $12.00 | $250,992 | 31,083 | D: show line 2 in the form |
| Open-market sales · 20,916 sh · avg $12.00 · $250,992 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Olivo Alicia C EVP, GC & Business Development | 2025-11-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,977 | 46,355 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1764364698.xml…